Latest Insider Positions

HAWARI KENNETH G is listed as an insider in the following companies: NVTR / Nuvectra Corporation Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.


Security Title Post Shares
NVTR / Nuvectra Director 24,538

Latest Transactions

Tran Date
Security Code Shares Post Shares Percent
2018-07-09 NVTR / Nuvectra M 838 24,538 3.54 17.36 14,548
2018-04-10 NVTR / Nuvectra M 837 23,700 3.66 13.53 11,325
2018-01-10 NVTR / Nuvectra M 837 22,863 3.80 9.79 8,194
2017-10-10 NVTR / Nuvectra M 838 22,026 3.96 13.87 11,623
2017-07-10 NVTR / Nuvectra M 838 21,188 4.12 12.73 10,668
2017-04-07 NVTR / Nuvectra M 837 20,350 4.29 6.36 5,323
2017-03-16 NVTR / Nuvectra P 17,000 19,513 676.48 6.14 104,380 119,810 87.12
2017-01-07 NVTR / Nuvectra M 837 2,513 49.94 5.58 4,670
2016-10-07 NVTR / Nuvectra M 839 1,676 100.24 6.53 5,479
2016-07-07 NVTR / Nuvectra M 837 3,350 33.31 7.24 6,060
2016-04-08 NVTR / Nuvectra A 3,350 3,350
Open market or private purchase of non-derivative or derivative security
Open market or private sale of non-derivative or derivative security
Grant, award, or other acquisition of securities from the company (such as an option)
Conversion of derivative
Sale or transfer of securities back to the company
Payment of exercise price or tax liability using portion of securities received from the company
Gift of securities by or to the insider
Equity swaps and similar hedging transactions
Exercise or conversion of derivative security received from the company (such as an option)
A transaction voluntarily reported on Form 4
Other (accompanied by a footnote describing the transaction)

Peers of HAWARI KENNETH G include the following: BERGER WALTER Z, Bihl Anthony P III, DREES SCOTT F, Fahey Kathy Jo, GREATBATCH, INC., Hanchin Joseph Paul, Hickman Thomas Kelley, JOHNSON DAVID D, Kaula Norbert, Kosharek Jennifer, MILLER JOSEPH A, PARKS FRED B, Tremmel Jon T, Zelibor Thomas Edward, . Peers are determined by cross-linking the filings of HAWARI KENNETH G with insider filings of others at the same companies.

Related News Stories

Nuvectra Corporation (NVTR) CEO Scott Drees on Q2 2018 Results - Earnings Call Transcript

2018-08-12 seekingalpha
Good day, ladies and gentlemen, and welcome to the Q2 2018 Nuvectra Earnings Conference Call. [Operator Instructions] As a reminder, this conference call may be recorded. (3-0)

Your Daily Pharma Scoop: Redhill's New Patent, Nuvectra Slips, Teligent Gains

2018-07-03 seekingalpha
RedHill Biopharma (RDHL) announced that two new patents covering Crohn's disease candidate RHB-104 are notified by USPTO and the European Patent Office. The candidate is currently in Phase 3 development. The patents will be in effect until 2029. The company has an important upcoming catalyst related to its RHB-104 candidate. Topline Phase 3 data of RHB-104 trial MAP-US on Crohn's disease expected in early August 2018. (27-2)

Why Nuvectra Is Monday’s Big Biotech Loser

2018-07-02 247wallst
Nuvectra Corp. (NASDAQ: NVTR) shares were crushed on Monday after the company announced an update on its U.S. Food and Drug Administration (FDA) premarket approval (PMA) application and its TÜV SÜD application for CE Mark in Europe for Virtis. (1-0)

Nuvectra Corporation's (NVTR) CEO Scott Drees on Q1 2018 Results - Earnings Call Transcript

2018-05-03 seekingalpha
Good day, ladies and gentlemen and welcome to the Q1 2018 Nuvectra Earnings Conference Call. [Operator Instructions] As a reminder, this conference call maybe recorded. (1-0)